Estrogen

Risk for venous thromboembolism does not differ for women using oral conjugated equine estrogen vs. oral or transdermal estradiol, according to a study published in Menopause.

In this video, Patrick Borgen, MD, chair of the department of surgery at Maimonides Medical Center, discussed the potential of using oral selective estrogen receptor degraders, or SERDs, in breast cancer at the 38th Annual Miami Breast Cancer Conference.

The loss of estrogen’s protective role in exercise capacity could contribute to the gender gap in overall health between men and women with cystic fibrosis, a presenter at the North American Cystic Fibrosis Conference suggested.

Early-onset of puberty and other pubertal parameters have been linked to a significantly increased risk for developing breast cancer later in life.

October is World Menopause Month. Healio and Endocrine Today have compiled a list of the most read recent news about menopause.

Fetal estrogens, considered “weak” steroid hormones detectable only during pregnancy, may improve the risk-benefit profile for the treatment of menopausal symptoms compared with current therapies, according to a speaker.

In May, Healio readers were interested in sex hormones being investigated for treating COVID-19, greater COVID-19 complications for patients with diabetes and obesity, associations between thyroid dysfunction and working hours, and more.

As researchers continue to assess complications of COVID-19, one striking difference has become clear — men who contract the novel coronavirus are more likely to be intubated or die compared with women. Animal model studies of the SARS virus suggest that the age and sex differences in COVID-19 symptom severity may be due to the protective and acute actions of estrogen, and researchers are initiating a trial designed to find out whether a transdermal estrogen patch placed on the skin of COVID-19-positive patients can reduce symptom severity compared with regular care.

Friday marks the 10th anniversary of World Menopause Day, established by the International Menopause Society to show support for women worldwide and recognize the challenges of menopausal symptoms and related conditions.

Longer endogenous estrogen exposure and use of hormone therapy are associated with higher cognitive status in late life, especially among older women when compared with younger women, according to findings published in Menopause.